PB1689 LEVELS OF BCL2 EXPRESSION AT POST-INDUCTION AND AT COMPLETE REMISSION IMPACT THE OUTCOME IN AML AND MAY IDENTIFY THOSE PATIENTS THAT WOULD BENEFIT OF BCL2 INHIBITORS

Authors: C. Bilbao, C. Rodríguez Medina, S. Sánchez Sosa, Y. Florido Ortega, M. D. L. N. Saez Perdomo, J. M. González Martín, E. González Pérez, R. Stuckey, R. Fernández, V. Peri, M. T. Molero Labarta, M. T. Gómez Casares

Published: 2019-06-17

DOI: 10.1097/01.hs9.0000565272.92117.9d

Source: Full article

---

Abstract

No abstract found.